000174586 000__ 01520fam\a2200361\a\4500
000174586 001__ 174586
000174586 005__ 20220217103527.0
000174586 008__ 930112s1992\\\\dcu\\\\\\b\\\f000\0\eng\d
000174586 020__ $$a0160397863
000174586 035__ $$a(OCoLC)ocm27235080
000174586 035__ $$9(IS)TVT2455
000174586 035__ $$9AAU2883SI
000174586 035__ $$a174586
000174586 040__ $$aFTC$$cFTC$$dGPO
000174586 043__ $$an-us---
000174586 049__ $$aISUW
000174586 074__ $$a1019-A
000174586 0860_ $$aY 4.EN 2/3:102-161
000174586 088__ $$aSerial no. 102-161 (United States. Congress. House. Committee on Energy and Commerce)
000174586 090__ $$aHD9666.6$$b.U5H8 1992b
000174586 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.$$bSubcommittee on Health and the Environment.
000174586 24510 $$aUser fees for prescription drugs :$$bhearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992.
000174586 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1992.
000174586 300__ $$aiii, 48 p. ;$$c24 cm.
000174586 500__ $$aDistributed to some depository libraries in microfiche.
000174586 500__ $$aShipping list no.: 93-0122-P.
000174586 500__ $$a"Serial no. 102-161."
000174586 504__ $$aIncludes bibliographical references.
000174586 61010 $$aUnited States.$$bFood and Drug Administration.
000174586 650_0 $$aPharmaceutical industry$$zUnited States.
000174586 650_0 $$aFees, Administrative$$zUnited States.
000174586 650_0 $$aUser charges$$zUnited States.
000174586 85230 $$bdfich$$hY 4.EN 2/3:$$i102-161
000174586 909CO $$ooai:library.usi.edu:174586$$pGLOBAL_SET
000174586 948__ $$ac:jk
000174586 980__ $$aBIB
000174586 980__ $$aGOV RESOURCE